Search research articles
Contact Us
Filters
Showing results (41-50 of 255) with videos related to
Page
of 26
Sort By:
Clinical Genitourinary Cancer
|
December 17, 2013
Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal
Tanya B Dorff, Cy Wilkins, Mehmet Hepgur, et al.
Cancer
|
January 25, 2017
Comparative effectiveness of screening strategies for colorectal cancer
Afsaneh Barzi, Heinz-Josef Lenz, David I Quinn, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 10, 2015
One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer
Hossein Jadvar, Sudha Challa, David I Quinn, et al.
BMC Cancer
|
December 18, 2014
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
Vishal Vashistha, David I Quinn, Tanya B Dorff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2016
What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer
Leslie K Ballas, Andre Luis de Castro Abreu, David I Quinn
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 2022
Oligometastatic Prostate Cancer: Current Status and Future Challenges
Hossein Jadvar, Andre Luis Abreu, Leslie K Ballas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2003
Molecular prognostication in bladder cancer--a current perspective
M L Quek, D I Quinn, S Daneshmand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2022
Bladder cancer: from a therapeutic wilderness to so many options; a guide to practice in a changing landscape
Anishka A D'souza, Varsha Tulpule, Peter D Zang, et al.
Maturitas
|
May 31, 2011
Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer
Eddie Thara, Tanya B Dorff, Jacek K Pinski, et al.
Human Vaccines & Immunotherapeutics
|
February 29, 2012
Blood cells and their use in active immunotherapy of prostate cancer
Shuang Yin Zhang, Eddie Thara, David I Quinn, et al.
Page
of 26
Search research articles
Search
Showing results (41-50 of 255) with videos related to
Sort By:
Page
of 26
Clinical Genitourinary Cancer
|
December 17, 2013
Durable complete remission from castration-resistant prostate cancer with sipuleucel-T after estrogen withdrawal
Tanya B Dorff, Cy Wilkins, Mehmet Hepgur, et al.
Cancer
|
January 25, 2017
Comparative effectiveness of screening strategies for colorectal cancer
Afsaneh Barzi, Heinz-Josef Lenz, David I Quinn, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 10, 2015
One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer
Hossein Jadvar, Sudha Challa, David I Quinn, et al.
BMC Cancer
|
December 18, 2014
Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review
Vishal Vashistha, David I Quinn, Tanya B Dorff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 4, 2016
What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer
Leslie K Ballas, Andre Luis de Castro Abreu, David I Quinn
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 1, 2022
Oligometastatic Prostate Cancer: Current Status and Future Challenges
Hossein Jadvar, Andre Luis Abreu, Leslie K Ballas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2003
Molecular prognostication in bladder cancer--a current perspective
M L Quek, D I Quinn, S Daneshmand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 13, 2022
Bladder cancer: from a therapeutic wilderness to so many options; a guide to practice in a changing landscape
Anishka A D'souza, Varsha Tulpule, Peter D Zang, et al.
Maturitas
|
May 31, 2011
Vaccine therapy with sipuleucel-T (Provenge) for prostate cancer
Eddie Thara, Tanya B Dorff, Jacek K Pinski, et al.
Human Vaccines & Immunotherapeutics
|
February 29, 2012
Blood cells and their use in active immunotherapy of prostate cancer
Shuang Yin Zhang, Eddie Thara, David I Quinn, et al.
Page
of 26